Five questions

I was interviewed by Media Bullseye, where I answered the following questions:

1) What prompted you to blog/use social media?

2) What benefits--direct and indirect--have you discovered using this communications tool?

3) Writing is tough work, and blogs, with the need to be updated on a fairly regular basis, can be particularly challenging. How do you stay inspired, and how do you keep things interesting?

4) ...

Read more...

Doctors and Twitter

We've talked earlier about the demise of the doctor's lounge.

But here's an example of the power of Twitter, a popular microblogging service. Imaging if doctors were connected here, and able to converse and curbside akin to a "virtual" lounge?

Take a look at this example, held within a span of 12 minutes.

Speaking of which, feel free to subscribe to this blog's
Read more...

Twitter and HIPAA

As if the firestorm over blogging about patients isn't hot enough, here are a couple of takes talking about those who Twitter about patients at work.

Although blogs and tweets about patients are often the most interesting, the privacy issues are the ones major media will focus on, and often stir up the most controversy. Don't assume that there is any anonymity on the web.

The ...

Read more...

Doctors on Twitter

Want to know what the medical community is thinking right this minute? Joshua Schwimmer mashed all the physician Twitter feeds he can find, and conveniently broadcast it in RSS. Enjoy.

There are several ways to follow the posts on Kevin, M.D. Apologies to those who find this tutorial too basic.


RSS is the main way. Standing for "Really Simply Syndication", RSS is a format for delivering regularly changing web content. Many news-related sites, weblogs and other online publishers syndicate their content as ...

Read more...

Twitter and Facebook

In case you're looking for other ways to keep up with Kevin, M.D., my posts are now broadcast on Twitter and updated continuously on Facebook.

Clinical Cases suggests using Twitter and Facebook to help manage asthma.

(Update 12/04 - This breaking news blog entry is moved to the top as the blogosphere continues to react.)

More on this HDL-raising drug's stunning collapse. There's talk Pfizer stock will drop to $20. I'm disappointed myself, since there is no reliable way to raise HDL, save for niacin and fibrates. I thought they were idiots not to test it alone, but only in conjunction with Lipitor. ...

Read more...

Most Popular

Join 150,000+ subscribers

Get the best of KevinMD in your inbox

Sign me up! It's free. 
close-link
✓ Join 150,000+ subscribers 
✓ Get KevinMD's 5 most popular stories
Subscribe. It's free.